This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Arnica montana
- DrugBank Accession Number
- DB14297
- Background
Arnica montana is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Experimental, Investigational
- Synonyms
- Arnica (Arnica Montana)
- Arnica Flower Oil
- Arnica Tincture
- European Arnica Whole
- Leopard's Bane Whole
- Mountain Arnica
- Mountain Arnica Whole
- Mountain Tobacco Whole
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Arnica Performance Gel Gel 150 mg/1mL Topical Myo-Breathe,LLC 2015-06-25 Not applicable US 
Sinecch Capsule 1 [hp_M]/1 Oral Hahnemann Laboratories 2022-12-09 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Medterra Pain Cream Arnica montana (0.07 g/1) + Menthol (0.02 g/1) Cream Topical RNA PHARMA, LLC 2020-02-17 Not applicable US Medterra Pain Cream Arnica montana (0.07 g/1) + Menthol (0.02 g/1) Cream Topical RNA PHARMA, LLC 2020-02-17 Not applicable US Medterra Pain Cream Arnica montana (0.07 g/1) + Menthol (0.02 g/1) Cream Topical RNA PHARMA, LLC 2020-02-17 Not applicable US Medterra Pain Cream Arnica montana (0.07 g/1) + Menthol (0.02 g/1) Cream Topical RNA PHARMA, LLC 2020-08-07 Not applicable US Medterra Pain Cream 1000 Arnica montana (0.07 g/1) + Menthol (0.04 g/1) Cream Topical RNA PHARMA, LLC 2021-01-18 Not applicable US Medterra Pain Cream 500 Arnica montana (0.07 g/1) + Menthol (0.02 g/1) Cream Topical RNA PHARMA, LLC 2020-03-24 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Arnica Performance Gel Arnica montana (150 mg/1mL) Gel Topical Myo-Breathe,LLC 2015-06-25 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- O80TY208ZW
- CAS number
- 8057-65-6
References
- General References
- Not Available
- External Links
- 285208
- Wikipedia
- Arnica_montana
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Supportive Care Impacted Third Molar Tooth 1 3 Terminated Treatment Pain 1 1 Completed Treatment Arnica / Exercise / Muscles 1 1 Recruiting Treatment Cutaneous Leishmaniasis 1 1 Unknown Status Prevention Hemorrhage 1 Not Available Completed Prevention Seroma 1 Not Available Completed Treatment Ecchymosis 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Topical 150 mg/1mL Gel Cutaneous Cream Topical Capsule Oral 1 [hp_M]/1 - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 17:42